Grazia Vivanet

Cagliari, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Real-world effectiveness of risankizumab in psoriasis: first Sardinian multicenter 2-year experience.

Real-world effectiveness of risankizumab in psoriasis: first Sardinian multicenter 2-year experience.

Journal: Italian journal of dermatology and venereology

Published: June 23, 2026

Tinea Capitis Induced by Barber Shaving: Isolation of Trichophyton tonsurans.

Tinea Capitis Induced by Barber Shaving: Isolation of Trichophyton tonsurans.

Journal: Journal of clinical medicine

Published: December 06, 2024

Correction to: Antifungal Stewardship in Invasive Fungal Infections, a Systematic Review.

Correction to: Antifungal Stewardship in Invasive Fungal Infections, a Systematic Review.

Journal: Advances in experimental medicine and biology

Published: May 13, 2024

Antifungal Stewardship in Invasive Fungal Infections, a Systematic Review.

Antifungal Stewardship in Invasive Fungal Infections, a Systematic Review.

Journal: Advances in experimental medicine and biology

Published: February 10, 2024

Primary malignant phyllodes tumors of the breast: A retrospective analysis from a referral center.

Primary malignant phyllodes tumors of the breast: A retrospective analysis from a referral center.

Journal: European journal of cancer (Oxford, England : 1990)

Published: September 29, 2023

Evolution of biological features of invasive lobular breast cancer: Comparison between primary tumour and metastases.

Evolution of biological features of invasive lobular breast cancer: Comparison between primary tumour and metastases.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 10, 2023

Immune-Related Adverse Event Likelihood Score Identifies "Pure" IRAEs Strongly Associated With Outcome in a Phase I-II Trial Population.

Immune-Related Adverse Event Likelihood Score Identifies "Pure" IRAEs Strongly Associated With Outcome in a Phase I-II Trial Population.

Journal: The oncologist

Published: December 19, 2022

High-dose continuous-infusion ifosfamide in advanced thymic epithelial Tumors: A TYME network study.

High-dose continuous-infusion ifosfamide in advanced thymic epithelial Tumors: A TYME network study.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: July 15, 2022

Loss of HER2 in breast cancer: biological mechanisms and technical pitfalls.

Loss of HER2 in breast cancer: biological mechanisms and technical pitfalls.

Journal: Cancer drug resistance (Alhambra, Calif.)

Published: April 18, 2022

SARS-CoV-2 vaccine in patients with thymic epithelial tumours with and without active or pre-existing autoimmune disorders: Brief report of a TYME network safety analysis.

SARS-CoV-2 vaccine in patients with thymic epithelial tumours with and without active or pre-existing autoimmune disorders: Brief report of a TYME network safety analysis.

Journal: European journal of cancer (Oxford, England : 1990)

Published: February 09, 2022

Evolution of low HER2 expression between early and advanced-stage breast cancer.

Evolution of low HER2 expression between early and advanced-stage breast cancer.

Journal: European journal of cancer (Oxford, England : 1990)

Published: November 08, 2021

Ten years-experience of sunitinib in the treatment of advanced pan-NETs: an update on safety profile.

Ten years-experience of sunitinib in the treatment of advanced pan-NETs: an update on safety profile.

Journal: Expert opinion on drug safety

Published: November 02, 2021

Showing 1-12 of 13

Last Updated: 09/26/2026